Nuveen Asset Management, LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$3,429,129
-31.5%
629,198
-15.7%
0.00%
-50.0%
Q2 2023$5,009,572
+46169.3%
746,583
-39.1%
0.00%
-50.0%
Q1 2023$10,827
+75.6%
1,226,140
+52.0%
0.00%
+100.0%
Q4 2022$6,164
-99.8%
806,793
+80.3%
0.00%
+100.0%
Q3 2022$3,186,000
-9.4%
447,451
+3.0%
0.00%0.0%
Q2 2022$3,516,000
-14.4%
434,590
+33.8%
0.00%0.0%
Q1 2022$4,109,000
-51.6%
324,822
+7.3%
0.00%
-66.7%
Q4 2021$8,494,000
-27.5%
302,698
-12.2%
0.00%
-25.0%
Q3 2021$11,717,000
-28.0%
344,732
-13.4%
0.00%
-20.0%
Q2 2021$16,273,000
+7.2%
398,255
+5.6%
0.01%0.0%
Q1 2021$15,181,000
-41.6%
377,094
-14.2%
0.01%
-44.4%
Q4 2020$25,974,000
+93.3%
439,258
+59.0%
0.01%
+80.0%
Q3 2020$13,438,000
+10.3%
276,316
+9.8%
0.01%0.0%
Q2 2020$12,180,000
+85.7%
251,758
+6.6%
0.01%
+66.7%
Q1 2020$6,560,000
+302.0%
236,121
+332.8%
0.00%
+200.0%
Q4 2019$1,632,000
-5.8%
54,554
-2.7%
0.00%0.0%
Q3 2019$1,733,000
+168.3%
56,088
+319.5%
0.00%
Q2 2019$646,00013,3700.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q4 2021
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders